{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:00:12Z","timestamp":1785492012172,"version":"3.56.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7759\/cureus.113706","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:39:59Z","timestamp":1785490799000},"source":"Crossref","is-referenced-by-count":0,"title":["Liver Imaging Reporting and Data System (LI-RADS): A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Tripti","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udit","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay J","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021, 149:778-89. 10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32355","article-title":"Declining disease burden of HCC in the United States, 1992-2017: a population-based analysis","volume":"76","author":"Han J","year":"2022","unstructured":"Han J, Wang B, Liu W, Wang S, Chen R, Chen M, Fu Z. Declining disease burden of HCC in the United States, 1992-2017: a population-based analysis. Hepatology. 2022, 76:576-88. 10.1002\/hep.32355","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach JK","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, et al.. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018, 67:358-80. 10.1002\/hep.29086","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10606-w","article-title":"ESR essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR","volume":"34","author":"Cannella R","year":"2024","unstructured":"Cannella R, Zins M, Brancatelli G. ESR essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR. Eur Radiol. 2024, 34:2127-39. 10.1007\/s00330-024-10606-w","journal-title":"Eur Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S186239","article-title":"LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance","volume":"6","author":"Elsayes KM","year":"2019","unstructured":"Elsayes KM, Kielar AZ, Chernyak V, et al.. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019, 6:49-69. 10.2147\/JHC.S186239","journal-title":"J Hepatocell Carcinoma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222801","article-title":"LI-RADS: looking back, looking forward","volume":"307","author":"Chernyak V","year":"2023","unstructured":"Chernyak V, Fowler KJ, Do RK, et al.. LI-RADS: looking back, looking forward. Radiology. 2023, 307:e222801. 10.1148\/radiol.222801","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1034","article-title":"LI-RADS: future directions","volume":"17","author":"Chernyak V","year":"2021","unstructured":"Chernyak V, Sirlin CB. LI-RADS: future directions. Clin Liver Dis (Hoboken). 2021, 17:149-53. 10.1002\/cld.1034","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000186","article-title":"Standardizing liver imaging reporting and interpretation: LI-RADS and beyond","volume":"7","author":"Rich NE","year":"2023","unstructured":"Rich NE, Chernyak V. Standardizing liver imaging reporting and interpretation: LI-RADS and beyond. Hepatol Commun. 2023, 7:10.1097\/HC9.0000000000000186","journal-title":"Hepatol Commun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03059-y","article-title":"Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies","volume":"46","author":"Eisenbrey JR","year":"2021","unstructured":"Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY). 2021, 46:3579-95. 10.1007\/s00261-021-03059-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref10","unstructured":"American College of Radiology. LI-RADS\u00ae Ultrasound Surveillance v2024 Core. (2024). Accessed. 01\/01\/2026: https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-US-...."},{"key":"ref11","unstructured":"American College of Radiology. LI-RADS\u00ae CT\/MRI v2018 Core. (2018). Accessed. 01\/01\/2026: https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-CT-...."},{"key":"ref12","unstructured":"American College of Radiology. CEUS LI-RADS\u00ae v2017 Core. (2017). Accessed. 01\/01\/2026: https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/LI-RADS\/CEUS-LI-RAD...."},{"key":"ref13","unstructured":"American College of Radiology. LI-RADS\u00ae CT\/MRI Radiation TRA v2024 Core. (2024). Accessed. 01\/01\/2026: https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-CTM...."},{"key":"ref14","unstructured":"American College of Radiology. LI-RADS\u00ae CT\/MRI Nonradiation TRA v2024 Core. (2024). Accessed. 01\/01\/2026: https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-CTM...."},{"key":"ref15","unstructured":"American College of Radiology. LI-RADS\u00ae CEUS Nonradiation TRA v2024 Core. (2024). Accessed. 01\/01\/2026: https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-CEU...."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2023.06.006","article-title":"Up-to-date role of Liver Imaging Reporting and Data System in hepatocellular carcinoma","volume":"33","author":"Chernyak V","year":"2024","unstructured":"Chernyak V. Up-to-date role of Liver Imaging Reporting and Data System in hepatocellular carcinoma. Surg Oncol Clin N Am. 2024, 33:59-72. 10.1016\/j.soc.2023.06.006","journal-title":"Surg Oncol Clin N Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.24272","article-title":"LI-RADS: past, present, and future, from the AJR special series on radiology reporting and data systems","volume":"216","author":"Marks RM","year":"2021","unstructured":"Marks RM, Masch WR, Chernyak V. LI-RADS: past, present, and future, from the AJR special series on radiology reporting and data systems. AJR Am J Roentgenol. 2021, 216:295-304. 10.2214\/AJR.20.24272","journal-title":"AJR Am J Roentgenol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04730-w","article-title":"LI-RADS in 2024: recent updates, planned refinements, and future directions","volume":"50","author":"Kierans AS","year":"2025","unstructured":"Kierans AS, Fowler KJ, Chernyak V. LI-RADS in 2024: recent updates, planned refinements, and future directions. Abdom Radiol (NY). 2025, 50:2868-80. 10.1007\/s00261-024-04730-w","journal-title":"Abdom Radiol (NY)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2020.06.004","article-title":"Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): an overview with technical and practical applications","volume":"28","author":"Choi HH","year":"2021","unstructured":"Choi HH, Rodgers SK, Fetzer DT, et al.. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): an overview with technical and practical applications. Acad Radiol. 2021, 28:1464-76. 10.1016\/j.acra.2020.06.004","journal-title":"Acad Radiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071655","article-title":"A narrative review on LI-RADS algorithm in liver tumors: prospects and pitfalls","volume":"12","author":"De Muzio F","year":"2022","unstructured":"De Muzio F, Grassi F, Dell'Aversana F, et al.. A narrative review on LI-RADS algorithm in liver tumors: prospects and pitfalls. Diagnostics (Basel). 2022, 12:1655. 10.3390\/diagnostics12071655","journal-title":"Diagnostics (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S268288","article-title":"Up-to-date role of CT\/MRI LI-RADS in hepatocellular carcinoma","volume":"8","author":"Moura Cunha G","year":"2021","unstructured":"Moura Cunha G, Chernyak V, Fowler KJ, Sirlin CB. Up-to-date role of CT\/MRI LI-RADS in hepatocellular carcinoma. J Hepatocell Carcinoma. 2021, 8:513-27. 10.2147\/JHC.S268288","journal-title":"J Hepatocell Carcinoma"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215118","article-title":"Hepatocellular carcinoma: Surveillance, diagnosis, evaluation and management","volume":"15","author":"Elderkin J","year":"2023","unstructured":"Elderkin J, Al Hallak N, Azmi AS, Aoun H, Critchfield J, Tobon M, Beal EW. Hepatocellular carcinoma: Surveillance, diagnosis, evaluation and management. Cancers (Basel). 2023, 15:5118. 10.3390\/cancers15215118","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018, 69:182-236. 10.1016\/j.jhep.2018.03.019","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2018.04.013","article-title":"Role of imaging in surveillance and diagnosis of hepatocellular carcinoma","volume":"47","author":"Gupta M","year":"2018","unstructured":"Gupta M, Gabriel H, Miller FH. Role of imaging in surveillance and diagnosis of hepatocellular carcinoma. Gastroenterol Clin North Am. 2018, 47:585-602. 10.1016\/j.gtc.2018.04.013","journal-title":"Gastroenterol Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.240169","article-title":"LI-RADS US surveillance version 2024 for surveillance of hepatocellular carcinoma: an update to the American College of Radiology US LI-RADS","volume":"313","author":"Kamaya A","year":"2024","unstructured":"Kamaya A, Fetzer DT, Seow JH, et al.. LI-RADS US surveillance version 2024 for surveillance of hepatocellular carcinoma: an update to the American College of Radiology US LI-RADS. Radiology. 2024, 313:e240169. 10.1148\/radiol.240169","journal-title":"Radiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2024.0161","article-title":"LI-RADS: current status and future directions","volume":"25","author":"Choi SH","year":"2024","unstructured":"Choi SH, Fowler KJ, Chernyak V, Sirlin CB. LI-RADS: current status and future directions. Korean J Radiol. 2024, 25:1039-46. 10.3348\/kjr.2024.0161","journal-title":"Korean J Radiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2017.06.012","article-title":"Screening and surveillance of hepatocellular carcinoma: an introduction to Ultrasound Liver Imaging Reporting and Data System","volume":"55","author":"Fetzer DT","year":"2017","unstructured":"Fetzer DT, Rodgers SK, Harris AC, Kono Y, Wasnik AP, Kamaya A, Sirlin C. Screening and surveillance of hepatocellular carcinoma: an introduction to Ultrasound Liver Imaging Reporting and Data System. Radiol Clin North Am. 2017, 55:1197-209. 10.1016\/j.rcl.2017.06.012","journal-title":"Radiol Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal AG","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, et al.. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023, 78:1922-65. 10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak V","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, et al.. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018, 289:816-30. 10.1148\/radiol.2018181494","journal-title":"Radiology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17506","article-title":"Review article: Available modalities for screening and imaging diagnosis of hepatocellular carcinoma\u2014current gaps and challenges","volume":"57","author":"Barnard Giustini A","year":"2023","unstructured":"Barnard Giustini A, Ioannou GN, Sirlin C, Loomba R. Review article: Available modalities for screening and imaging diagnosis of hepatocellular carcinoma\u2014current gaps and challenges. Aliment Pharmacol Ther. 2023, 57:1056-65. 10.1111\/apt.17506","journal-title":"Aliment Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03067-y","article-title":"Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) visualization score: a reliability analysis on inter-reader agreement","volume":"46","author":"Tiyarattanachai T","year":"2021","unstructured":"Tiyarattanachai T, Bird KN, Lo EC, et al.. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) visualization score: a reliability analysis on inter-reader agreement. Abdom Radiol (NY). 2021, 46:5134-41. 10.1007\/s00261-021-03067-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1862-z","article-title":"Association of advanced hepatic fibrosis and sonographic visualization score: a dual-center study using ACR US LI-RADS","volume":"44","author":"Choi HH","year":"2019","unstructured":"Choi HH, Perez MG, Millet JD, Liang T, Wasnik AP, Maturen KE, Kamaya A. Association of advanced hepatic fibrosis and sonographic visualization score: a dual-center study using ACR US LI-RADS. Abdom Radiol (NY). 2019, 44:1415-22. 10.1007\/s00261-018-1862-z","journal-title":"Abdom Radiol (NY)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2023.07.008","article-title":"Ultrasound LI-RADS visualization scores on surveillance ultrasound for hepatocellular carcinoma: a systematic review with meta-analysis","volume":"49","author":"Kang JH","year":"2023","unstructured":"Kang JH, Kim NH, Kim DH, Choi Y, Choi JI. Ultrasound LI-RADS visualization scores on surveillance ultrasound for hepatocellular carcinoma: a systematic review with meta-analysis. Ultrasound Med Biol. 2023, 49:2205-12. 10.1016\/j.ultrasmedbio.2023.07.008","journal-title":"Ultrasound Med Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2025.08.032","article-title":"ACR Appropriateness Criteria\u00ae staging and follow-up of primary liver cancer","volume":"22","author":"Smith EN","year":"2025","unstructured":"Smith EN, Bashir MR, Fung A, et al.. ACR Appropriateness Criteria\u00ae staging and follow-up of primary liver cancer. J Am Coll Radiol. 2025, 22:S699-712. 10.1016\/j.jacr.2025.08.032","journal-title":"J Am Coll Radiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04678-x","article-title":"Patient centered HCC surveillance - complementary roles of ultrasound and CT\/MRI","volume":"50","author":"Heald J","year":"2025","unstructured":"Heald J, Fetzer DT, Rodgers S, et al.. Patient centered HCC surveillance - complementary roles of ultrasound and CT\/MRI. Abdom Radiol (NY). 2025, 50:2088-96. 10.1007\/s00261-024-04678-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.041","article-title":"Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis","volume":"75","author":"Gupta P","year":"2021","unstructured":"Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N. Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol. 2021, 75:108-19. 10.1016\/j.jhep.2021.01.041","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000339","article-title":"Screening of liver cancer with abbreviated MRI","volume":"78","author":"Ronot M","year":"2023","unstructured":"Ronot M, Nahon P, Rimola J. Screening of liver cancer with abbreviated MRI. Hepatology. 2023, 78:670-86. 10.1097\/HEP.0000000000000339","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122975","article-title":"Meta-analysis of the accuracy of abbreviated magnetic resonance imaging for hepatocellular carcinoma surveillance: non-contrast versus hepatobiliary phase-abbreviated magnetic resonance imaging","volume":"13","author":"Kim DH","year":"2021","unstructured":"Kim DH, Choi SH, Shim JH, Kim SY, Lee SS, Byun JH, Choi JI. Meta-analysis of the accuracy of abbreviated magnetic resonance imaging for hepatocellular carcinoma surveillance: non-contrast versus hepatobiliary phase-abbreviated magnetic resonance imaging. Cancers (Basel). 2021, 13:2975. 10.3390\/cancers13122975","journal-title":"Cancers (Basel)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26835","article-title":"Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using LI-RADS v2018","volume":"51","author":"Khatri G","year":"2020","unstructured":"Khatri G, Pedrosa I, Ananthakrishnan L, et al.. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using LI-RADS v2018. J Magn Reson Imaging. 2020, 51:415-25. 10.1002\/jmri.26835","journal-title":"J Magn Reson Imaging"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2026.01.008","article-title":"Screening for hepatocellular carcinoma with ultrasound","volume":"64","author":"McGillen KL","year":"2026","unstructured":"McGillen KL, Oppenheimer DC, LeBedis CA, Hong CW, Fung CI. Screening for hepatocellular carcinoma with ultrasound. Radiol Clin North Am. 2026, 64:465-74. 10.1016\/j.rcl.2026.01.008","journal-title":"Radiol Clin North Am"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1317-y","article-title":"US LI-RADS: Ultrasound Liver Imaging and Reporting Data System for screening and surveillance of hepatocellular carcinoma","volume":"43","author":"Morgan TA","year":"2018","unstructured":"Morgan TA, Maturen KE, Dahiya N, Sun MR, Kamaya A. US LI-RADS: Ultrasound Liver Imaging and Reporting Data System for screening and surveillance of hepatocellular carcinoma. Abdom Radiol (NY). 2018, 43:41-55. 10.1007\/s00261-017-1317-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.24.32433","article-title":"LI-RADS ultrasound surveillance version 2024: comparison with version 2017 for hepatocellular carcinoma detection and risk factors for visualization score C","volume":"224","author":"Heo S","year":"2025","unstructured":"Heo S, Kim SY, Lee SJ, et al.. LI-RADS ultrasound surveillance version 2024: comparison with version 2017 for hepatocellular carcinoma detection and risk factors for visualization score C. AJR Am J Roentgenol. 2025, 224:e2432433. 10.2214\/AJR.24.32433","journal-title":"AJR Am J Roentgenol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1250-0","article-title":"CEUS LI-RADS: algorithm, implementation, and key differences from CT\/MRI","volume":"43","author":"Wilson SR","year":"2018","unstructured":"Wilson SR, Lyshchik A, Piscaglia F, et al.. CEUS LI-RADS: algorithm, implementation, and key differences from CT\/MRI. Abdom Radiol (NY). 2018, 43:127-42. 10.1007\/s00261-017-1250-0","journal-title":"Abdom Radiol (NY)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1392-0","article-title":"Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS Working Group","volume":"43","author":"Lyshchik A","year":"2018","unstructured":"Lyshchik A, Kono Y, Dietrich CF, et al.. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS Working Group. Abdom Radiol (NY). 2018, 43:861-79. 10.1007\/s00261-017-1392-0","journal-title":"Abdom Radiol (NY)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-123931","article-title":"How to perform contrast-enhanced ultrasound (CEUS)","volume":"4","author":"Dietrich CF","year":"2018","unstructured":"Dietrich CF, Averkiou M, Nielsen MB, et al.. How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open. 2018, 4:E2-15. 10.1055\/s-0043-123931","journal-title":"Ultrasound Int Open"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2021.05.006","article-title":"Contrast-enhanced ultrasound in chronic liver diseases","volume":"29","author":"Spann S","year":"2021","unstructured":"Spann S, Fetzer DT. Contrast-enhanced ultrasound in chronic liver diseases. Magn Reson Imaging Clin N Am. 2021, 29:291-304. 10.1016\/j.mric.2021.05.006","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040625","article-title":"Imaging diagnosis of hepatocellular carcinoma: a state-of-the-art review","volume":"13","author":"Candita G","year":"2023","unstructured":"Candita G, Rossi S, Cwiklinska K, Fanni SC, Cioni D, Lencioni R, Neri E. Imaging diagnosis of hepatocellular carcinoma: a state-of-the-art review. Diagnostics (Basel). 2023, 13:625. 10.3390\/diagnostics13040625","journal-title":"Diagnostics (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0819-2","article-title":"CEUS LI-RADS: a pictorial review","volume":"11","author":"Bartolotta TV","year":"2020","unstructured":"Bartolotta TV, Terranova MC, Gagliardo C, Taibbi A. CEUS LI-RADS: a pictorial review. Insights Imaging. 2020, 11:9. 10.1186\/s13244-019-0819-2","journal-title":"Insights Imaging"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/jum.15837","article-title":"The value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the diagnosis of hepatocellular carcinoma: a meta-analysis","volume":"41","author":"Peng J","year":"2022","unstructured":"Peng J, Zhang T, Wang H, Ma X. The value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the diagnosis of hepatocellular carcinoma: a meta-analysis. J Ultrasound Med. 2022, 41:1537-47. 10.1002\/jum.15837","journal-title":"J Ultrasound Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5152-x","article-title":"Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis","volume":"28","author":"Wu M","year":"2018","unstructured":"Wu M, Li L, Wang J, Zhang Y, Guo Q, Li X, Zhang X. Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis. Eur Radiol. 2018, 28:2077-88. 10.1007\/s00330-017-5152-x","journal-title":"Eur Radiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.007","article-title":"Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restrospective study of 1,006 nodules","volume":"68","author":"Terzi E","year":"2018","unstructured":"Terzi E, Iavarone M, Pompili M, et al.. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restrospective study of 1,006 nodules. J Hepatol. 2018, 68:485-92. 10.1016\/j.jhep.2017.11.007","journal-title":"J Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1055\/a-1198-4874","article-title":"Contrast-enhanced ultrasound algorithms (CEUS-LIRADS\/ESCULAP) for the noninvasive diagnosis of hepatocellular carcinoma - a prospective multicenter DEGUM study","volume":"42","author":"Schellhaas B","year":"2021","unstructured":"Schellhaas B, Bernatik T, Bohle W, et al.. Contrast-enhanced ultrasound algorithms (CEUS-LIRADS\/ESCULAP) for the noninvasive diagnosis of hepatocellular carcinoma - a prospective multicenter DEGUM study. Ultraschall Med. 2021, 42:178-86. 10.1055\/a-1198-4874","journal-title":"Ultraschall Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07872-3","article-title":"Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS\u00ae\/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study","volume":"31","author":"Strobel D","year":"2021","unstructured":"Strobel D, Jung EM, Ziesch M, et al.. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS\u00ae\/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study. Eur Radiol. 2021, 31:7614-25. 10.1007\/s00330-021-07872-3","journal-title":"Eur Radiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.21037\/qims-22-591","article-title":"LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"Jin H","year":"2023","unstructured":"Jin H, Cai Y, Zhang M, et al.. LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis. Quant Imaging Med Surg. 2023, 13:957-69. 10.21037\/qims-22-591","journal-title":"Quant Imaging Med Surg"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2022.01.041","article-title":"Risk stratification for hepatocellular carcinoma of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis","volume":"77","author":"Qin Z","year":"2022","unstructured":"Qin Z, Zhou Y, Ding J, Wen J, Chen Y, Zhou H, Jing X. Risk stratification for hepatocellular carcinoma of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis. Clin Radiol. 2022, 77:e280-6. 10.1016\/j.crad.2022.01.041","journal-title":"Clin Radiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14617","article-title":"Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System for diagnosing hepatocellular carcinoma: a meta-analysis","volume":"40","author":"Shin J","year":"2020","unstructured":"Shin J, Lee S, Bae H, Chung YE, Choi JY, Huh YM, Park MS. Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System for diagnosing hepatocellular carcinoma: a meta-analysis. Liver Int. 2020, 40:2345-52. 10.1111\/liv.14617","journal-title":"Liver Int"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1077","article-title":"Using LI-RADS with contrast-enhanced ultrasound","volume":"17","author":"Rodgers SK","year":"2021","unstructured":"Rodgers SK, Fetzer DT, Kono Y. Using LI-RADS with contrast-enhanced ultrasound. Clin Liver Dis (Hoboken). 2021, 17:154-8. 10.1002\/cld.1077","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020323","article-title":"Clinical application of Liver Imaging Reporting and Data System for characterizing liver neoplasms: a meta-analysis","volume":"11","author":"Li L","year":"2021","unstructured":"Li L, Hu Y, Han J, Li Q, Peng C, Zhou J. Clinical application of Liver Imaging Reporting and Data System for characterizing liver neoplasms: a meta-analysis. Diagnostics (Basel). 2021, 11:323. 10.3390\/diagnostics11020323","journal-title":"Diagnostics (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1055\/a-1309-1568","article-title":"Diagnostic accuracy of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for differentiating between hepatocellular carcinoma and other hepatic malignancies in high-risk patients: a meta-analysis","volume":"42","author":"Li J","year":"2021","unstructured":"Li J, Yang L, Ma L, Lu Q, Luo Y. Diagnostic accuracy of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for differentiating between hepatocellular carcinoma and other hepatic malignancies in high-risk patients: a meta-analysis. Ultraschall Med. 2021, 42:187-93. 10.1055\/a-1309-1568","journal-title":"Ultraschall Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-015-0402-4","article-title":"Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation","volume":"6","author":"Lorusso A","year":"2015","unstructured":"Lorusso A, Quaia E, Poillucci G, Stacul F, Grisi G, Cova MA. Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation. Insights Imaging. 2015, 6:499-508. 10.1007\/s13244-015-0402-4","journal-title":"Insights Imaging"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04305-9","article-title":"Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT\/MRI in patients at risk for HCC","volume":"49","author":"Kono Y","year":"2024","unstructured":"Kono Y, Piscaglia F, Wilson SR, et al.. Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT\/MRI in patients at risk for HCC. Abdom Radiol (NY). 2024, 49:2639-49. 10.1007\/s00261-024-04305-9","journal-title":"Abdom Radiol (NY)"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.240916","article-title":"Contrast-enhanced US of high-risk indeterminate focal liver observations categorized as LR-4 or LR-M at CT\/MRI","volume":"314","author":"Lyshchik A","year":"2025","unstructured":"Lyshchik A, Kuon Yeng Escalante C, Siu Xiao T, et al.. Contrast-enhanced US of high-risk indeterminate focal liver observations categorized as LR-4 or LR-M at CT\/MRI. Radiology. 2025, 314:e240916. 10.1148\/radiol.240916","journal-title":"Radiology"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-025-01995-z","article-title":"The role of contrast-enhanced ultrasound in the radiological classification of liver observations identified by CT and MRI","volume":"130","author":"Huang H","year":"2025","unstructured":"Huang H, He DN, Lu RF, et al.. The role of contrast-enhanced ultrasound in the radiological classification of liver observations identified by CT and MRI. Radiol Med. 2025, 130:805-16. 10.1007\/s11547-025-01995-z","journal-title":"Radiol Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02132-x","article-title":"Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (\u2265\u20092\u00a0cm) of CT\/MRI for high-risk patients: focusing on the CT\/MRI LI-RADS categories LR-3 and LR-4","volume":"45","author":"Kang HJ","year":"2020","unstructured":"Kang HJ, Kim JH, Joo I, Han JK. Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (\u2265\u20092\u00a0cm) of CT\/MRI for high-risk patients: focusing on the CT\/MRI LI-RADS categories LR-3 and LR-4. Abdom Radiol (NY). 2020, 45:55-63. 10.1007\/s00261-019-02132-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2020.01.023","article-title":"Comparison of contrast-enhanced ultrasound versus contrast-enhanced magnetic resonance imaging for the diagnosis of focal liver lesions using the Liver Imaging Reporting and Data System","volume":"46","author":"Wang JY","year":"2020","unstructured":"Wang JY, Feng SY, Yi AJ, et al.. Comparison of contrast-enhanced ultrasound versus contrast-enhanced magnetic resonance imaging for the diagnosis of focal liver lesions using the Liver Imaging Reporting and Data System. Ultrasound Med Biol. 2020, 46:1216-23. 10.1016\/j.ultrasmedbio.2020.01.023","journal-title":"Ultrasound Med Biol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000558","article-title":"Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System: clinical validation in a prospective multinational study in North America and Europe","volume":"79","author":"Lyshchik A","year":"2024","unstructured":"Lyshchik A, Wessner CE, Bradigan K, et al.. Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System: clinical validation in a prospective multinational study in North America and Europe. Hepatology. 2024, 79:380-91. 10.1097\/HEP.0000000000000558","journal-title":"Hepatology"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i22.5589","article-title":"Interobserver agreement for contrast-enhanced ultrasound of liver imaging reporting and data system: a systematic review and meta-analysis","volume":"8","author":"Li J","year":"2020","unstructured":"Li J, Chen M, Wang ZJ, et al.. Interobserver agreement for contrast-enhanced ultrasound of liver imaging reporting and data system: a systematic review and meta-analysis. World J Clin Cases. 2020, 8:5589-602. 10.12998\/wjcc.v8.i22.5589","journal-title":"World J Clin Cases"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03169-7","article-title":"Inter-reader reliability of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System: a meta-analysis","volume":"46","author":"Kang JH","year":"2021","unstructured":"Kang JH, Choi SH, Lee JS, Kim DW, Jang JK. Inter-reader reliability of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System: a meta-analysis. Abdom Radiol (NY). 2021, 46:4671-81. 10.1007\/s00261-021-03169-7","journal-title":"Abdom Radiol (NY)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03468-7","article-title":"Diagnostic performance and interreader agreement of CEUS LI-RADS in\u2009\u2264\u200930\u00a0mm liver nodules with different experienced radiologists","volume":"47","author":"Wen R","year":"2022","unstructured":"Wen R, Lin P, Gao R, et al.. Diagnostic performance and interreader agreement of CEUS LI-RADS in\u2009\u2264\u200930\u00a0mm liver nodules with different experienced radiologists. Abdom Radiol (NY). 2022, 47:1798-805. 10.1007\/s00261-022-03468-7","journal-title":"Abdom Radiol (NY)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1002\/jum.16608","article-title":"Inter-reader agreement for Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System major features and final categorization: a subanalysis from a prospective multicenter study","volume":"44","author":"Kuon Yeng Escalante CM","year":"2025","unstructured":"Kuon Yeng Escalante CM, Siu Xiao T, Kono Y, et al.. Inter-reader agreement for Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System major features and final categorization: a subanalysis from a prospective multicenter study. J Ultrasound Med. 2025, 44:349-57. 10.1002\/jum.16608","journal-title":"J Ultrasound Med"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-023-01088-1","article-title":"Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC","volume":"23","author":"Wen R","year":"2023","unstructured":"Wen R, Huang W, Song R, et al.. Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC. BMC Med Imaging. 2023, 23:122. 10.1186\/s12880-023-01088-1","journal-title":"BMC Med Imaging"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20201359","article-title":"Tumor size-based validation of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) 2017 for hepatocellular carcinoma characterizing","volume":"94","author":"Pan JM","year":"2021","unstructured":"Pan JM, Chen W, Zheng YL, et al.. Tumor size-based validation of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) 2017 for hepatocellular carcinoma characterizing. Br J Radiol. 2021, 94:20201359. 10.1259\/bjr.20201359","journal-title":"Br J Radiol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019191086","article-title":"Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma","volume":"294","author":"Huang JY","year":"2020","unstructured":"Huang JY, Li JW, Lu Q, et al.. Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma. Radiology. 2020, 294:329-39. 10.1148\/radiol.2019191086","journal-title":"Radiology"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.21037\/qims-23-1184","article-title":"The efficacy of modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"14","author":"Liu Q","year":"2024","unstructured":"Liu Q, Liu T, Liu X, Zhang F, Yang J, Cheng Y, Yang Q. The efficacy of modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Quant Imaging Med Surg. 2024, 14:2927-37. 10.21037\/qims-23-1184","journal-title":"Quant Imaging Med Surg"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230150","article-title":"Contrast-enhanced US with sulfur hexafluoride and perfluorobutane: LI-RADS for diagnosing hepatocellular carcinoma","volume":"308","author":"Li L","year":"2023","unstructured":"Li L, Zou X, Zheng W, et al.. Contrast-enhanced US with sulfur hexafluoride and perfluorobutane: LI-RADS for diagnosing hepatocellular carcinoma. Radiology. 2023, 308:e230150. 10.1148\/radiol.230150","journal-title":"Radiology"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-04881-4","article-title":"LI-RADS for diagnosing hepatocellular carcinoma by contrast-enhanced US with SonoVue and Sonazoid\u2014a single center prospective study","volume":"50","author":"Lin C","year":"2025","unstructured":"Lin C, Yang XH, Zhai HY, Zhu XY, Zhou GM. LI-RADS for diagnosing hepatocellular carcinoma by contrast-enhanced US with SonoVue and Sonazoid\u2014a single center prospective study. Abdom Radiol (NY). 2025, 50:4971-80. 10.1007\/s00261-025-04881-4","journal-title":"Abdom Radiol (NY)"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200115","article-title":"Contrast-enhanced US with sulfur hexafluoride and perfluorobutane for the diagnosis of hepatocellular carcinoma in individuals with high risk","volume":"297","author":"Kang HJ","year":"2020","unstructured":"Kang HJ, Lee JM, Yoon JH, Lee K, Kim H, Han JK. Contrast-enhanced US with sulfur hexafluoride and perfluorobutane for the diagnosis of hepatocellular carcinoma in individuals with high risk. Radiology. 2020, 297:108-16. 10.1148\/radiol.2020200115","journal-title":"Radiology"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.252271","article-title":"Contrast-enhanced US using perfluorobutane for diagnosing small HCC in high-risk patients: comparison with MRI LI-RADS version 2018","volume":"318","author":"Li Y","year":"2026","unstructured":"Li Y, Lu S, Mao S, et al.. Contrast-enhanced US using perfluorobutane for diagnosing small HCC in high-risk patients: comparison with MRI LI-RADS version 2018. Radiology. 2026, 318:e252271. 10.1148\/radiol.252271","journal-title":"Radiology"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04250-7","article-title":"Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma","volume":"49","author":"Guo D","year":"2024","unstructured":"Guo D, Wan W, Bai X, et al.. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma. Abdom Radiol (NY). 2024, 49:1432-43. 10.1007\/s00261-024-04250-7","journal-title":"Abdom Radiol (NY)"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.21037\/qims-23-1616","article-title":"Compared with SonoVue\u00ae LR-5, Sonazoid\u00ae modified LR-5 has better diagnostic sensitivity for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"14","author":"Cao J","year":"2024","unstructured":"Cao J, Wang H, Ling W. Compared with SonoVue\u00ae LR-5, Sonazoid\u00ae modified LR-5 has better diagnostic sensitivity for hepatocellular carcinoma: a systematic review and meta-analysis. Quant Imaging Med Surg. 2024, 14:2978-92. 10.21037\/qims-23-1616","journal-title":"Quant Imaging Med Surg"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2024.03.016","article-title":"Dynamic contrast-enhanced ultrasonography combined with LR-M classification criteria for differentiating malignant liver nodules at high risk for hepatocellular carcinoma","volume":"50","author":"Qiu S","year":"2024","unstructured":"Qiu S, Ding J, Wang Y, et al.. Dynamic contrast-enhanced ultrasonography combined with LR-M classification criteria for differentiating malignant liver nodules at high risk for hepatocellular carcinoma. Ultrasound Med Biol. 2024, 50:1028-33. 10.1016\/j.ultrasmedbio.2024.03.016","journal-title":"Ultrasound Med Biol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1220-6","article-title":"LI-RADS\u00ae ancillary features on CT and MRI","volume":"43","author":"Chernyak V","year":"2018","unstructured":"Chernyak V, Tang A, Flusberg M, Papadatos D, Bijan B, Kono Y, Santillan C. LI-RADS\u00ae ancillary features on CT and MRI. Abdom Radiol (NY). 2018, 43:82-100. 10.1007\/s00261-017-1220-6","journal-title":"Abdom Radiol (NY)"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-017-0132-y","article-title":"Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update","volume":"12","author":"Granata V","year":"2017","unstructured":"Granata V, Fusco R, Avallone A, et al.. Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infect Agent Cancer. 2017, 12:23. 10.1186\/s13027-017-0132-y","journal-title":"Infect Agent Cancer"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1409-8","article-title":"Hepatocarcinogenesis and LI-RADS","volume":"43","author":"Narsinh KH","year":"2018","unstructured":"Narsinh KH, Cui J, Papadatos D, Sirlin CB, Santillan CS. Hepatocarcinogenesis and LI-RADS. Abdom Radiol (NY). 2018, 43:158-68. 10.1007\/s00261-017-1409-8","journal-title":"Abdom Radiol (NY)"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019190005","article-title":"State of the art: LI-RADS for contrast-enhanced US","volume":"293","author":"Quaia E","year":"2019","unstructured":"Quaia E. State of the art: LI-RADS for contrast-enhanced US. Radiology. 2019, 293:4-14. 10.1148\/radiol.2019190005","journal-title":"Radiology"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2017.0037","article-title":"Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) 2017 - a review of important differences compared to the CT\/MRI system","volume":"23","author":"Kim TK","year":"2017","unstructured":"Kim TK, Noh SY, Wilson SR, et al.. Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) 2017 - a review of important differences compared to the CT\/MRI system. Clin Mol Hepatol. 2017, 23:280-9. 10.3350\/cmh.2017.0037","journal-title":"Clin Mol Hepatol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.14366\/usg.19052","article-title":"LI-RADS ancillary features on contrast-enhanced ultrasonography","volume":"39","author":"Dietrich CF","year":"2020","unstructured":"Dietrich CF, Dong Y, Kono Y, Caraiani C, Sirlin CB, Cui XW, Tang A. LI-RADS ancillary features on contrast-enhanced ultrasonography. Ultrasonography. 2020, 39:221-8. 10.14366\/usg.19052","journal-title":"Ultrasonography"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/biology10050412","article-title":"CT\/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017\u2014Can things be put together?","volume":"10","author":"Caraiani C","year":"2021","unstructured":"Caraiani C, Boca B, Bura V, Sparchez Z, Dong Y, Dietrich C. CT\/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017\u2014Can things be put together?. Biology (Basel). 2021, 10:412. 10.3390\/biology10050412","journal-title":"Biology (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017170098","article-title":"2017 version of LI-RADS for CT and MR imaging: an update","volume":"37","author":"Elsayes KM","year":"2017","unstructured":"Elsayes KM, Hooker JC, Agrons MM, et al.. 2017 version of LI-RADS for CT and MR imaging: an update. Radiographics. 2017, 37:1994-2017. 10.1148\/rg.2017170098","journal-title":"Radiographics"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.10.014","article-title":"Introduction to the Liver Imaging Reporting and Data System for hepatocellular carcinoma","volume":"17","author":"Tang A","year":"2019","unstructured":"Tang A, Singal AG, Mitchell DG, et al.. Introduction to the Liver Imaging Reporting and Data System for hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2019, 17:1228-38. 10.1016\/j.cgh.2018.10.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1002\/cld.991","article-title":"LI-RADS: review and updates","volume":"17","author":"Elmohr M","year":"2021","unstructured":"Elmohr M, Elsayes KM, Chernyak V. LI-RADS: review and updates. Clin Liver Dis (Hoboken). 2021, 17:108-12. 10.1002\/cld.991","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1744-4","article-title":"White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI","volume":"43","author":"Elsayes KM","year":"2018","unstructured":"Elsayes KM, Kielar AZ, Elmohr MM, et al.. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY). 2018, 43:2625-42. 10.1007\/s00261-018-1744-4","journal-title":"Abdom Radiol (NY)"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222971","article-title":"Conversion strategy for LI-RADS category 5 observations across versions 2014, 2017, and 2018","volume":"307","author":"Goins SM","year":"2023","unstructured":"Goins SM, Adamo RG, Lam E, et al.. Conversion strategy for LI-RADS category 5 observations across versions 2014, 2017, and 2018. Radiology. 2023, 307:e222971. 10.1148\/radiol.222971","journal-title":"Radiology"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26570","article-title":"The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: alignment with Liver Imaging Reporting and Data System, current gaps, and future direction","volume":"29","author":"Kierans AS","year":"2023","unstructured":"Kierans AS, Chernyak V, Mendiratta-Lala M, Sirlin CB, Hecht EM, Fowler KJ. The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: alignment with Liver Imaging Reporting and Data System, current gaps, and future direction. Liver Transpl. 2023, 29:206-16. 10.1002\/lt.26570","journal-title":"Liver Transpl"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero JA","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al.. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018, 68:723-50. 10.1002\/hep.29913","journal-title":"Hepatology"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1209-1","article-title":"Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis","volume":"43","author":"Tang A","year":"2018","unstructured":"Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY). 2018, 43:13-25. 10.1007\/s00261-017-1209-1","journal-title":"Abdom Radiol (NY)"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04589-x","article-title":"Diagnostic performance of CT\/MRI LI-RADS v2018 in non-cirrhotic hepatitis C virus infection","volume":"50","author":"Cao JJ","year":"2025","unstructured":"Cao JJ, Shon A, Yoon L, Kamaya A, Tse JR. Diagnostic performance of CT\/MRI LI-RADS v2018 in non-cirrhotic hepatitis C virus infection. Abdom Radiol (NY). 2025, 50:1615-23. 10.1007\/s00261-024-04589-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1774305","article-title":"CT MRI LI-RADS in routine practice","volume":"6","author":"Ganesan K","year":"2023","unstructured":"Ganesan K, Jalkote S, Nellore S. CT MRI LI-RADS in routine practice. J Gastrointest Abdom Radiol. 2023, 6:173-84. 10.1055\/s-0043-1774305","journal-title":"J Gastrointest Abdom Radiol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220646","article-title":"Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis","volume":"307","author":"Lee S","year":"2023","unstructured":"Lee S, Kim YY, Shin J, et al.. Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis. Radiology. 2023, 307:e220646. 10.1148\/radiol.220646","journal-title":"Radiology"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08985-z","article-title":"Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies","volume":"32","author":"Kim YY","year":"2022","unstructured":"Kim YY, Lee S, Shin J, Son WJ, Roh YH, Hwang JA, Lee JE. Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies. Eur Radiol. 2022, 32:6723-9. 10.1007\/s00330-022-08985-z","journal-title":"Eur Radiol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2019.0363","article-title":"Intraindividual comparison between gadoxetate-enhanced magnetic resonance imaging and dynamic computed tomography for characterizing focal hepatic lesions: a multicenter, multireader study","volume":"20","author":"An C","year":"2019","unstructured":"An C, Lee CH, Byun JH, et al.. Intraindividual comparison between gadoxetate-enhanced magnetic resonance imaging and dynamic computed tomography for characterizing focal hepatic lesions: a multicenter, multireader study. Korean J Radiol. 2019, 20:1616-26. 10.3348\/kjr.2019.0363","journal-title":"Korean J Radiol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26540","article-title":"Use of gadoxetate disodium in patients with chronic liver disease and its implications for Liver Imaging Reporting and Data System (LI-RADS)","volume":"49","author":"Chernyak V","year":"2019","unstructured":"Chernyak V, Fowler KJ, Heiken JP, Sirlin CB. Use of gadoxetate disodium in patients with chronic liver disease and its implications for Liver Imaging Reporting and Data System (LI-RADS). J Magn Reson Imaging. 2019, 49:1236-52. 10.1002\/jmri.26540","journal-title":"J Magn Reson Imaging"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23397-1","article-title":"MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid","volume":"12","author":"Collettini F","year":"2022","unstructured":"Collettini F, Elkilany A, Seta MD, et al.. MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid. Sci Rep. 2022, 12:18583. 10.1038\/s41598-022-23397-1","journal-title":"Sci Rep"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26199","article-title":"Added value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19\u2009mm) or atypical hepatic observations at contrast-enhanced CT: a prospective comparison","volume":"49","author":"Yoon JH","year":"2019","unstructured":"Yoon JH, Lee JM, Lee YJ, Lee KB, Han JK. Added value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19\u2009mm) or atypical hepatic observations at contrast-enhanced CT: a prospective comparison. J Magn Reson Imaging. 2019, 49:574-87. 10.1002\/jmri.26199","journal-title":"J Magn Reson Imaging"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1868-6","article-title":"CT\/MR LI-RADS 2018: clinical implications and management recommendations","volume":"44","author":"Kamath A","year":"2019","unstructured":"Kamath A, Roudenko A, Hecht E, Sirlin C, Chernyak V, Fowler K, Mitchell DG. CT\/MR LI-RADS 2018: clinical implications and management recommendations. Abdom Radiol (NY). 2019, 44:1306-22. 10.1007\/s00261-018-1868-6","journal-title":"Abdom Radiol (NY)"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2021200205","article-title":"How to use LI-RADS to report liver CT and MRI observations","volume":"41","author":"M Cunha G","year":"2021","unstructured":"M Cunha G, Fowler KJ, Roudenko A, et al.. How to use LI-RADS to report liver CT and MRI observations. Radiographics. 2021, 41:1352-67. 10.1148\/rg.2021200205","journal-title":"Radiographics"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03726-8","article-title":"Optional MRI sequences for LI-RADS: Why, what, and how?","volume":"48","author":"Kamal O","year":"2023","unstructured":"Kamal O, Sy E, Chernyak V, et al.. Optional MRI sequences for LI-RADS: Why, what, and how?. Abdom Radiol (NY). 2023, 48:519-31. 10.1007\/s00261-022-03726-8","journal-title":"Abdom Radiol (NY)"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.680691","article-title":"Accuracy of various forms of contrast-enhanced MRI for diagnosing hepatocellular carcinoma: a systematic review and meta-analysis","volume":"11","author":"Zhao C","year":"2021","unstructured":"Zhao C, Dai H, Shao J, et al.. Accuracy of various forms of contrast-enhanced MRI for diagnosing hepatocellular carcinoma: a systematic review and meta-analysis. Front Oncol. 2021, 11:680691. 10.3389\/fonc.2021.680691","journal-title":"Front Oncol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-21540-8_4","article-title":"Radiological diagnosis and characterization of HCC","author":"Vietti Violi N","year":"2019","unstructured":"Vietti Violi N, Lewis S, Hectors S, Said D, Taouli B. Radiological diagnosis and characterization of HCC. Hepatocellular Carcinoma. Molecular and Translational Medicine. Hoshida Y (ed): Springer, Cham, Switzerland; 2019. 6:71-92. 10.1007\/978-3-030-21540-8_4"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241260331","article-title":"Comparison of the ability of gadobenate dimeglumine and gadolinium ethoxybenzyl dimeglumine to display the major features for noninvasively diagnosing hepatocellular carcinoma according to the LI-RADS 2018v","volume":"23","author":"Yao WW","year":"2024","unstructured":"Yao WW, Zhang HW, M YP, et al.. Comparison of the ability of gadobenate dimeglumine and gadolinium ethoxybenzyl dimeglumine to display the major features for noninvasively diagnosing hepatocellular carcinoma according to the LI-RADS 2018v. Technol Cancer Res Treat. 2024, 23:10.1177\/15330338241260331","journal-title":"Technol Cancer Res Treat"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26818","article-title":"Comparison of gadobenate-enhanced MRI and gadoxetate-enhanced MRI for hepatocellular carcinoma detection using LI-RADS version 2018: a prospective intraindividual randomized study","volume":"218","author":"Rong D","year":"2022","unstructured":"Rong D, He B, Tang W, et al.. Comparison of gadobenate-enhanced MRI and gadoxetate-enhanced MRI for hepatocellular carcinoma detection using LI-RADS version 2018: a prospective intraindividual randomized study. AJR Am J Roentgenol. 2022, 218:687-98. 10.2214\/AJR.21.26818","journal-title":"AJR Am J Roentgenol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27065","article-title":"Interreader agreement of Liver Imaging Reporting and Data System on MRI: a systematic review and meta-analysis","volume":"52","author":"Kang JH","year":"2020","unstructured":"Kang JH, Choi SH, Lee JS, et al.. Interreader agreement of Liver Imaging Reporting and Data System on MRI: a systematic review and meta-analysis. J Magn Reson Imaging. 2020, 52:795-804. 10.1002\/jmri.27065","journal-title":"J Magn Reson Imaging"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1177\/0846537119888393","article-title":"Liver Imaging Reporting and Data System (LI-RADS) v2018: review of the CT\/MRI diagnostic categories","volume":"72","author":"Kanmaniraja D","year":"2021","unstructured":"Kanmaniraja D, Dellacerra G, Holder J, Erlichman D, Chernyak V. Liver Imaging Reporting and Data System (LI-RADS) v2018: review of the CT\/MRI diagnostic categories. Can Assoc Radiol J. 2021, 72:142-9. 10.1177\/0846537119888393","journal-title":"Can Assoc Radiol J"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1291-4","article-title":"LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents","volume":"43","author":"Santillan C","year":"2018","unstructured":"Santillan C, Fowler K, Kono Y, Chernyak V. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents. Abdom Radiol (NY). 2018, 43:75-81. 10.1007\/s00261-017-1291-4","journal-title":"Abdom Radiol (NY)"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1334-x","article-title":"LI-RADS categories: concepts, definitions, and criteria","volume":"43","author":"Santillan C","year":"2018","unstructured":"Santillan C, Chernyak V, Sirlin C. LI-RADS categories: concepts, definitions, and criteria. Abdom Radiol (NY). 2018, 43:101-10. 10.1007\/s00261-017-1334-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03270-x","article-title":"Tumor in vein (LR-TIV) and Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications","volume":"46","author":"Catania R","year":"2021","unstructured":"Catania R, Chupetlovska K, Borhani AA, Maheshwari E, Furlan A. Tumor in vein (LR-TIV) and Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications. Abdom Radiol (NY). 2021, 46:5723-34. 10.1007\/s00261-021-03270-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07282-x","article-title":"The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis","volume":"31","author":"Kim DH","year":"2021","unstructured":"Kim DH, Choi SH, Park SH, et al.. The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis. Eur Radiol. 2021, 31:2497-506. 10.1007\/s00330-020-07282-x","journal-title":"Eur Radiol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1196-2","article-title":"LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma","volume":"43","author":"Fowler KJ","year":"2018","unstructured":"Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol (NY). 2018, 43:149-57. 10.1007\/s00261-017-1196-2","journal-title":"Abdom Radiol (NY)"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2021.05.012","article-title":"Liver Imaging Reporting and Data System comprehensive guide: MR imaging edition","volume":"29","author":"Elmohr MM","year":"2021","unstructured":"Elmohr MM, Chernyak V, Sirlin CB, Elsayes KM. Liver Imaging Reporting and Data System comprehensive guide: MR imaging edition. Magn Reson Imaging Clin N Am. 2021, 29:375-87. 10.1016\/j.mric.2021.05.012","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-026-05383-7","article-title":"Focal \"Targetoid\" liver lesions on MRI: a diagnostic and practical imaging approach","author":"Maldonado Schoijet I","year":"2026","unstructured":"Maldonado Schoijet I, Retamales Rojas K, Schiappacasse Faundes G, Guachalla Figueroa M, Menias C. Focal \"Targetoid\" liver lesions on MRI: a diagnostic and practical imaging approach. Abdom Radiol (NY). 2026, 10.1007\/s00261-026-05383-7","journal-title":"Abdom Radiol (NY)"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03538-w","article-title":"New strategy for Liver Imaging Reporting and Data System category M to improve diagnostic performance of MRI for hepatocellular carcinoma\u2009\u2264\u20093.0\u00a0cm","volume":"47","author":"Jang JK","year":"2022","unstructured":"Jang JK, Choi SH, Byun JH, et al.. New strategy for Liver Imaging Reporting and Data System category M to improve diagnostic performance of MRI for hepatocellular carcinoma\u2009\u2264\u20093.0\u00a0cm. Abdom Radiol (NY). 2022, 47:2289-98. 10.1007\/s00261-022-03538-w","journal-title":"Abdom Radiol (NY)"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-05132-2","article-title":"LR-M for CT\/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective","volume":"51","author":"Low G","year":"2026","unstructured":"Low G, Pfanner T, Qian XJ, Ramji A, Samji K, Wilson MP. LR-M for CT\/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective. Abdom Radiol (NY). 2026, 51:1332-46. 10.1007\/s00261-025-05132-2","journal-title":"Abdom Radiol (NY)"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-04960-6","article-title":"Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysis","volume":"50","author":"Nedrud M","year":"2025","unstructured":"Nedrud M, Wolfson T, Allen B, et al.. Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysis. Abdom Radiol (NY). 2025, 50:5232-41. 10.1007\/s00261-025-04960-6","journal-title":"Abdom Radiol (NY)"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2020-0029","article-title":"Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma","volume":"54","author":"Granata V","year":"2020","unstructured":"Granata V, Fusco R, Venanzio Setola S, et al.. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma. Radiol Oncol. 2020, 54:149-58. 10.2478\/raon-2020-0029","journal-title":"Radiol Oncol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-02996-y","article-title":"Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018","volume":"46","author":"Zou X","year":"2021","unstructured":"Zou X, Luo Y, Morelli JN, Hu X, Shen Y, Hu D. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018. Abdom Radiol (NY). 2021, 46:3168-78. 10.1007\/s00261-021-02996-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14420","article-title":"Liver Imaging Reporting and Data System category M: a systematic review and meta-analysis","volume":"40","author":"Kim DH","year":"2020","unstructured":"Kim DH, Choi SH, Park SH, et al.. Liver Imaging Reporting and Data System category M: a systematic review and meta-analysis. Liver Int. 2020, 40:1477-87. 10.1111\/liv.14420","journal-title":"Liver Int"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08382-y","article-title":"MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis","volume":"32","author":"Shin J","year":"2022","unstructured":"Shin J, Lee S, Hwang JA, Lee JE, Chung YE, Choi JY, Park MS. MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis. Eur Radiol. 2022, 32:3319-26. 10.1007\/s00330-021-08382-y","journal-title":"Eur Radiol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018171678","article-title":"LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features","volume":"288","author":"Cerny M","year":"2018","unstructured":"Cerny M, Bergeron C, Billiard JS, et al.. LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Radiology. 2018, 288:118-28. 10.1148\/radiol.2018171678","journal-title":"Radiology"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.21037\/cco-20-107","article-title":"Imaging diagnosis of hepatocellular carcinoma: LI-RADS","volume":"10","author":"Cunha GM","year":"2021","unstructured":"Cunha GM, Sirlin CB, Fowler KJ. Imaging diagnosis of hepatocellular carcinoma: LI-RADS. Chin Clin Oncol. 2021, 10:3. 10.21037\/cco-20-107","journal-title":"Chin Clin Oncol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29748","article-title":"Current state of evidence for use of MRI in LI-RADS","volume":"62","author":"Kulkarni AM","year":"2025","unstructured":"Kulkarni AM, Kruse D, Harper K, et al.. Current state of evidence for use of MRI in LI-RADS. J Magn Reson Imaging. 2025, 62:640-53. 10.1002\/jmri.29748","journal-title":"J Magn Reson Imaging"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2015.0140","article-title":"Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - part 2","volume":"50","author":"Ramalho M","year":"2017","unstructured":"Ramalho M, Matos AP, AlObaidy M, Velloni F, Altun E, Semelka RC. Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - part 2. Radiol Bras. 2017, 50:115-25. 10.1590\/0100-3984.2015.0140","journal-title":"Radiol Bras"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.231501","article-title":"LI-RADS CT and MRI ancillary feature association with hepatocellular carcinoma and malignancy: an individual participant data meta-analysis","volume":"310","author":"Dawit H","year":"2024","unstructured":"Dawit H, Lam E, McInnes MD, et al.. LI-RADS CT and MRI ancillary feature association with hepatocellular carcinoma and malignancy: an individual participant data meta-analysis. Radiology. 2024, 310:e231501. 10.1148\/radiol.231501","journal-title":"Radiology"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03380-6","article-title":"Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M","volume":"47","author":"Zheng W","year":"2022","unstructured":"Zheng W, Huang H, She D, Xiong M, Chen X, Lin X, Cao D. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M. Abdom Radiol (NY). 2022, 47:957-68. 10.1007\/s00261-021-03380-6","journal-title":"Abdom Radiol (NY)"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257308","article-title":"Hepatobiliary phase signal intensity: a potential method of diagnosing HCC with atypical imaging features among LR-M observations","volume":"16","author":"Park JH","year":"2021","unstructured":"Park JH, Chung YE, Seo N, Choi JY, Park MS, Kim MJ. Hepatobiliary phase signal intensity: a potential method of diagnosing HCC with atypical imaging features among LR-M observations. PLoS One. 2021, 16:e0257308. 10.1371\/journal.pone.0257308","journal-title":"PLoS One"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06698-9","article-title":"Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations \u2265\u200910\u00a0mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma","volume":"30","author":"Cannella R","year":"2020","unstructured":"Cannella R, Vernuccio F, Sagreiya H, Choudhury KR, Iranpour N, Marin D, Furlan A. Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations \u2265\u200910\u00a0mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma. Eur Radiol. 2020, 30:3770-81. 10.1007\/s00330-020-06698-9","journal-title":"Eur Radiol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06645-3","article-title":"Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma \u2264\u20093\u00a0cm on magnetic resonance imaging","volume":"30","author":"Kang JH","year":"2020","unstructured":"Kang JH, Choi SH, Byun JH, et al.. Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma \u2264\u20093\u00a0cm on magnetic resonance imaging. Eur Radiol. 2020, 30:2881-9. 10.1007\/s00330-019-06645-3","journal-title":"Eur Radiol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.22802","article-title":"MRI ancillary features for LI-RADS category 3 and 4 observations: improved categorization to indicate the risk of hepatic malignancy","volume":"215","author":"Kim YY","year":"2020","unstructured":"Kim YY, Choi JY, Kim SU, Lee M, Park MS, Chung YE, Kim MJ. MRI ancillary features for LI-RADS category 3 and 4 observations: improved categorization to indicate the risk of hepatic malignancy. AJR Am J Roentgenol. 2020, 215:1354-62. 10.2214\/AJR.20.22802","journal-title":"AJR Am J Roentgenol"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.26.34591","article-title":"Interreader agreement for individual ancillary features in LI-RADS CT\/MRI version 2018: a systematic review and meta-analysis","author":"Jung YJ","year":"2026","unstructured":"Jung YJ, Choi SH, Heo S, Kim DH, Kim S, Hong SB. Interreader agreement for individual ancillary features in LI-RADS CT\/MRI version 2018: a systematic review and meta-analysis. AJR Am J Roentgenol. 2026, 10.2214\/AJR.26.34591","journal-title":"AJR Am J Roentgenol"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.23031","article-title":"MRI LI-RADS version 2018: impact of and reduction in ancillary features","volume":"216","author":"van der Pol CB","year":"2021","unstructured":"van der Pol CB, Dhindsa K, Shergill R, et al.. MRI LI-RADS version 2018: impact of and reduction in ancillary features. AJR Am J Roentgenol. 2021, 216:935-42. 10.2214\/AJR.20.23031","journal-title":"AJR Am J Roentgenol"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1097\/RCT.0000000000000995","article-title":"Liver Imaging Reporting and Data System version 2018: what radiologists need to know","volume":"44","author":"Abdel Razek AA","year":"2020","unstructured":"Abdel Razek AA, El-Serougy LG, Saleh GA, Shabana W, Abd El-Wahab R. Liver Imaging Reporting and Data System version 2018: what radiologists need to know. J Comput Assist Tomogr. 2020, 44:168-77. 10.1097\/RCT.0000000000000995","journal-title":"J Comput Assist Tomogr"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1055\/a-1990-5924","article-title":"LI-RADS made easy","volume":"195","author":"Schima W","year":"2023","unstructured":"Schima W, Kopf H, Eisenhuber E. LI-RADS made easy. Rofo. 2023, 195:486-94. 10.1055\/a-1990-5924","journal-title":"Rofo"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017170554","article-title":"Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review","volume":"286","author":"Tang A","year":"2018","unstructured":"Tang A, Bashir MR, Corwin MT, et al.. Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology. 2018, 286:29-48. 10.1148\/radiol.2017170554","journal-title":"Radiology"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1093\/bjr\/tqaf123","article-title":"Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond","volume":"98","author":"Haghshomar M","year":"2025","unstructured":"Haghshomar M, Kierans AS, Kulik L, Miller FH, Borhani AA. Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond. Br J Radiol. 2025, 98:1344-55. 10.1093\/bjr\/tqaf123","journal-title":"Br J Radiol"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07815-y","article-title":"Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis","volume":"31","author":"Kang JH","year":"2021","unstructured":"Kang JH, Choi SH, Lee JS, Kim KW, Kim SY, Lee SS, Byun JH. Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis. Eur Radiol. 2021, 31:6856-67. 10.1007\/s00330-021-07815-y","journal-title":"Eur Radiol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211244","article-title":"CT\/MRI and CEUS LI-RADS major features association with hepatocellular carcinoma: individual patient data meta-analysis","volume":"302","author":"van der Pol CB","year":"2022","unstructured":"van der Pol CB, McInnes MD, Salameh JP, et al.. CT\/MRI and CEUS LI-RADS major features association with hepatocellular carcinoma: individual patient data meta-analysis. Radiology. 2022, 302:326-35. 10.1148\/radiol.2021211244","journal-title":"Radiology"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27570","article-title":"LI-RADS major features on MRI for diagnosing hepatocellular carcinoma: a systematic review and meta-analysis","volume":"54","author":"Shin J","year":"2021","unstructured":"Shin J, Lee S, Yoon JK, Chung YE, Choi JY, Park MS. LI-RADS major features on MRI for diagnosing hepatocellular carcinoma: a systematic review and meta-analysis. J Magn Reson Imaging. 2021, 54:518-25. 10.1002\/jmri.27570","journal-title":"J Magn Reson Imaging"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20979","article-title":"LI-RADS: diagnostic performance of hepatobiliary phase hypointensity and major imaging features of LR-3 and LR-4 lesions measuring 10-19 mm with arterial phase hyperenhancement","volume":"213","author":"Vernuccio F","year":"2019","unstructured":"Vernuccio F, Cannella R, Meyer M, et al.. LI-RADS: diagnostic performance of hepatobiliary phase hypointensity and major imaging features of LR-3 and LR-4 lesions measuring 10-19 mm with arterial phase hyperenhancement. AJR Am J Roentgenol. 2019, 213:W57-65. 10.2214\/AJR.18.20979","journal-title":"AJR Am J Roentgenol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08665-y","article-title":"Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis","volume":"32","author":"Pan J","year":"2022","unstructured":"Pan J, Tao Y, Chi X, Yang L, Zhao Y, Chen F. Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis. Eur Radiol. 2022, 32:5134-43. 10.1007\/s00330-022-08665-y","journal-title":"Eur Radiol"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-023-01161-9","article-title":"Threshold growth has a limited role in differentiating hepatocellular carcinoma from other focal hepatic lesions","volume":"23","author":"Lyu R","year":"2023","unstructured":"Lyu R, Wang D, Hu W, et al.. Threshold growth has a limited role in differentiating hepatocellular carcinoma from other focal hepatic lesions. BMC Med Imaging. 2023, 23:201. 10.1186\/s12880-023-01161-9","journal-title":"BMC Med Imaging"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2020.1341","article-title":"Should threshold growth be considered a major feature in the diagnosis of hepatocellular carcinoma using LI-RADS?","volume":"22","author":"Park JH","year":"2021","unstructured":"Park JH, Chung YE, Seo N, Choi JY, Park MS, Kim MJ. Should threshold growth be considered a major feature in the diagnosis of hepatocellular carcinoma using LI-RADS?. Korean J Radiol. 2021, 22:1628-39. 10.3348\/kjr.2020.1341","journal-title":"Korean J Radiol"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26839","article-title":"User and system pitfalls in liver imaging with LI-RADS","volume":"50","author":"Elsayes KM","year":"2019","unstructured":"Elsayes KM, Fowler KJ, Chernyak V, et al.. User and system pitfalls in liver imaging with LI-RADS. J Magn Reson Imaging. 2019, 50:1673-86. 10.1002\/jmri.26839","journal-title":"J Magn Reson Imaging"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.12169","article-title":"LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas","volume":"203","author":"Jha RC","year":"2014","unstructured":"Jha RC, Mitchell DG, Weinreb JC, Santillan CS, Yeh BM, Francois R, Sirlin CB. LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas. AJR Am J Roentgenol. 2014, 203:W48-69. 10.2214\/AJR.13.12169","journal-title":"AJR Am J Roentgenol"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i32.4540","article-title":"Liver Imaging Reporting and Data System criteria for the diagnosis of hepatocellular carcinoma in clinical practice: a pictorial minireview","volume":"28","author":"Liava C","year":"2022","unstructured":"Liava C, Sinakos E, Papadopoulou E, et al.. Liver Imaging Reporting and Data System criteria for the diagnosis of hepatocellular carcinoma in clinical practice: a pictorial minireview. World J Gastroenterol. 2022, 28:4540-56. 10.3748\/wjg.v28.i32.4540","journal-title":"World J Gastroenterol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26640","article-title":"Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017","volume":"50","author":"Ren AH","year":"2019","unstructured":"Ren AH, Zhao PF, Yang DW, Du JB, Wang ZC, Yang ZH. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017. J Magn Reson Imaging. 2019, 50:746-55. 10.1002\/jmri.26640","journal-title":"J Magn Reson Imaging"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.31661\/jbpe.v0i0.2211-1562","article-title":"Evidence supporting diagnostic value of Liver Imaging Reporting and Data System for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"14","author":"Suhail Najm Alareer H","year":"2024","unstructured":"Suhail Najm Alareer H, Arian A, Fotouhi M, Taher HJ, Dinar Abdullah A. Evidence supporting diagnostic value of Liver Imaging Reporting and Data System for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. J Biomed Phys Eng. 2024, 14:5-20. 10.31661\/jbpe.v0i0.2211-1562","journal-title":"J Biomed Phys Eng"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36082","article-title":"Diagnostic values of the Liver Imaging Reporting and Data System in the detection and characterization of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"15","author":"Arian A","year":"2023","unstructured":"Arian A, Abdullah AD, Taher HJ, Suhail Alareer H, Fotouhi M. Diagnostic values of the Liver Imaging Reporting and Data System in the detection and characterization of hepatocellular carcinoma: a systematic review and meta-analysis. Cureus. 2023, 15:e36082. 10.7759\/cureus.36082","journal-title":"Cureus"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109404","article-title":"Diagnostic performance of LI-RADS for MRI and CT detection of HCC: a systematic review and diagnostic meta-analysis","volume":"134","author":"Liang Y","year":"2021","unstructured":"Liang Y, Xu F, Guo Y, et al.. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: a systematic review and diagnostic meta-analysis. Eur J Radiol. 2021, 134:109404. 10.1016\/j.ejrad.2020.109404","journal-title":"Eur J Radiol"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2022.03.093","article-title":"Efficacy of LR-5 and LR-4\/5 by Liver Imaging Reporting and Data System (MRI) for hepatocellular carcinoma: a meta-analysis","volume":"46","author":"Jin H","year":"2023","unstructured":"Jin H, Huang J, Zhang M, et al.. Efficacy of LR-5 and LR-4\/5 by Liver Imaging Reporting and Data System (MRI) for hepatocellular carcinoma: a meta-analysis. Asian J Surg. 2023, 46:82-8. 10.1016\/j.asjsur.2022.03.093","journal-title":"Asian J Surg"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2020.06.005","article-title":"CT and MRI Liver Imaging Reporting and Data System version 2018 for hepatocellular carcinoma: a systematic review with meta-analysis","volume":"17","author":"Lee S","year":"2020","unstructured":"Lee S, Kim YY, Shin J, Hwang SH, Roh YH, Chung YE, Choi JY. CT and MRI Liver Imaging Reporting and Data System version 2018 for hepatocellular carcinoma: a systematic review with meta-analysis. J Am Coll Radiol. 2020, 17:1199-206. 10.1016\/j.jacr.2020.06.005","journal-title":"J Am Coll Radiol"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10134-z","article-title":"Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis","volume":"34","author":"Lee S","year":"2024","unstructured":"Lee S, Kim YY, Shin J, Roh YH, Choi JY, Chernyak V, Sirlin CB. Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis. Eur Radiol. 2024, 34:1502-14. 10.1007\/s00330-023-10134-z","journal-title":"Eur Radiol"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-01948-x","article-title":"Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018","volume":"44","author":"Ludwig DR","year":"2019","unstructured":"Ludwig DR, Fraum TJ, Cannella R, et al.. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018. Abdom Radiol (NY). 2019, 44:2116-32. 10.1007\/s00261-019-01948-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-026-02290-9","article-title":"The 2024 LI-RADS treatment response update: practical reporting after non-radiation and radiation locoregional therapies for hepatocellular carcinoma","volume":"17","author":"Lu\u010dev J","year":"2026","unstructured":"Lu\u010dev J. The 2024 LI-RADS treatment response update: practical reporting after non-radiation and radiation locoregional therapies for hepatocellular carcinoma. Insights Imaging. 2026, 17:121. 10.1186\/s13244-026-02290-9","journal-title":"Insights Imaging"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04611-2","article-title":"LI-RADS radiation-based treatment response algorithm for HCC: what to know and how to use it","volume":"50","author":"Harmath C","year":"2025","unstructured":"Harmath C, Fung A, Aslam A, et al.. LI-RADS radiation-based treatment response algorithm for HCC: what to know and how to use it. Abdom Radiol (NY). 2025, 50:2012-21. 10.1007\/s00261-024-04611-2","journal-title":"Abdom Radiol (NY)"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-026-05380-w","article-title":"Performance of the LI-RADS treatment response algorithm v2024: a systematic review and meta-analysis of response assessment accuracy and non-definitive categories","volume":"51","author":"Zare M","year":"2026","unstructured":"Zare M, Mohebbi A, Abdi A, Mohammadi A. Performance of the LI-RADS treatment response algorithm v2024: a systematic review and meta-analysis of response assessment accuracy and non-definitive categories. Abdom Radiol (NY). 2026, 51:3870-82. 10.1007\/s00261-026-05380-w","journal-title":"Abdom Radiol (NY)"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247720","article-title":"Accuracy of contrast-enhanced ultrasound for hepatocellular carcinoma post-transcatheter arterial embolization","volume":"13","author":"McGillen KL","year":"2024","unstructured":"McGillen KL, Pryor WW 3rd, Yee NS, Zhu J, Krok KL, Waybill PN. Accuracy of contrast-enhanced ultrasound for hepatocellular carcinoma post-transcatheter arterial embolization. J Clin Med. 2024, 13:7720. 10.3390\/jcm13247720","journal-title":"J Clin Med"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.06.005","article-title":"Evaluation of the contrast-enhanced ultrasound nonradiation treatment response assessment LI-RADS v2024 using data from a multi-center transarterial chemoembolization study","volume":"31","author":"Kuon Yeng Escalante CM","year":"2024","unstructured":"Kuon Yeng Escalante CM, Siu Xiao T, Nagaraj RU, et al.. Evaluation of the contrast-enhanced ultrasound nonradiation treatment response assessment LI-RADS v2024 using data from a multi-center transarterial chemoembolization study. Acad Radiol. 2024, 31:5078-86. 10.1016\/j.acra.2024.06.005","journal-title":"Acad Radiol"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0801-z","article-title":"Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review","volume":"10","author":"Voizard N","year":"2019","unstructured":"Voizard N, Cerny M, Assad A, et al.. Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights Imaging. 2019, 10:121. 10.1186\/s13244-019-0801-z","journal-title":"Insights Imaging"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28659","article-title":"Updates on LI-RADS treatment response criteria for hepatocellular carcinoma: focusing on MRI","volume":"57","author":"Patel R","year":"2023","unstructured":"Patel R, Aslam A, Parikh ND, et al.. Updates on LI-RADS treatment response criteria for hepatocellular carcinoma: focusing on MRI. J Magn Reson Imaging. 2023, 57:1641-54. 10.1002\/jmri.28659","journal-title":"J Magn Reson Imaging"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1281-6","article-title":"Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm","volume":"43","author":"Kielar A","year":"2018","unstructured":"Kielar A, Fowler KJ, Lewis S, et al.. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018, 43:218-30. 10.1007\/s00261-017-1281-6","journal-title":"Abdom Radiol (NY)"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-05110-8","article-title":"LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies","volume":"51","author":"Wakate Teruya AK","year":"2026","unstructured":"Wakate Teruya AK, Miranda J, Le\u00e3o Filho H, Lahan-Martins D, Tamura Sttefano Guimaraes C, Blasbalg R, Velloni FG. LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies. Abdom Radiol (NY). 2026, 51:1289-311. 10.1007\/s00261-025-05110-8","journal-title":"Abdom Radiol (NY)"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-026-05469-2","article-title":"Contrast-enhanced ultrasound LI-RADS nonradiation treatment response assessment: applications, challenges, and future directions","author":"Fetzer DT","year":"2026","unstructured":"Fetzer DT, Kono Y, Piscaglia F, et al.. Contrast-enhanced ultrasound LI-RADS nonradiation treatment response assessment: applications, challenges, and future directions. Abdom Radiol (NY). 2026, 10.1007\/s00261-026-05469-2","journal-title":"Abdom Radiol (NY)"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232369","article-title":"Liver Imaging Reporting and Data System contrast-enhanced US nonradiation treatment response assessment version 2024","volume":"311","author":"Lyshchik A","year":"2024","unstructured":"Lyshchik A, Fetzer DT, Kono Y, et al.. Liver Imaging Reporting and Data System contrast-enhanced US nonradiation treatment response assessment version 2024. Radiology. 2024, 311:e232369. 10.1148\/radiol.232369","journal-title":"Radiology"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.25.33787","article-title":"LI-RADS CT\/MRI nonradiation treatment response assessment version 2024 for detecting local recurrence of surgically resected hepatocellular carcinoma","volume":"226","author":"Chiu SH","year":"2026","unstructured":"Chiu SH, Yoon L, Altmayer S, Delitto DJ, Kamaya A, Tse JR. LI-RADS CT\/MRI nonradiation treatment response assessment version 2024 for detecting local recurrence of surgically resected hepatocellular carcinoma. AJR Am J Roentgenol. 2026, 226:e2533787. 10.2214\/AJR.25.33787","journal-title":"AJR Am J Roentgenol"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.14366\/usg.20057","article-title":"The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using sonazoid","volume":"39","author":"Lee JY","year":"2020","unstructured":"Lee JY, Minami Y, Choi BI, et al.. The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using sonazoid. Ultrasonography. 2020, 39:191-220. 10.14366\/usg.20057","journal-title":"Ultrasonography"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1097\/RCT.0000000000001789","article-title":"Response assessment in hepatocellular carcinoma: a primer for radiologists","volume":"50","author":"Mroueh N","year":"2026","unstructured":"Mroueh N, Cao J, Srinivas Rao S, et al.. Response assessment in hepatocellular carcinoma: a primer for radiologists. J Comput Assist Tomogr. 2026, 50:167-79. 10.1097\/RCT.0000000000001789","journal-title":"J Comput Assist Tomogr"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232408","article-title":"CT\/MRI LI-RADS 2024 update: treatment response assessment","volume":"313","author":"Aslam A","year":"2024","unstructured":"Aslam A, Chernyak V, Tang A, et al.. CT\/MRI LI-RADS 2024 update: treatment response assessment. Radiology. 2024, 313:e232408. 10.1148\/radiol.232408","journal-title":"Radiology"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1148\/rg.250067","article-title":"CT and MRI LI-RADS treatment response assessment 2024: core concepts for clinical practice","volume":"46","author":"Naves GG","year":"2026","unstructured":"Naves GG, Dantas PP, J\u00fanior AE, et al.. CT and MRI LI-RADS treatment response assessment 2024: core concepts for clinical practice. Radiographics. 2026, 46:e250067. 10.1148\/rg.250067","journal-title":"Radiographics"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i10.738","article-title":"Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: lessons learned and future directions","volume":"12","author":"Aslam A","year":"2020","unstructured":"Aslam A, Do RK, Kambadakone A, et al.. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: lessons learned and future directions. World J Hepatol. 2020, 12:738-53. 10.4254\/wjh.v12.i10.738","journal-title":"World J Hepatol"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.3348\/jksr.2025.0028","article-title":"LI-RADS CT\/MRI treatment response assessment update in 2024","volume":"86","author":"Shin J","year":"2025","unstructured":"Shin J, Gu K, Min JH. LI-RADS CT\/MRI treatment response assessment update in 2024. J Korean Soc Radiol. 2025, 86:352-63. 10.3348\/jksr.2025.0028","journal-title":"J Korean Soc Radiol"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2018180052","article-title":"LI-RADS version 2018 ancillary features at MRI","volume":"38","author":"Cerny M","year":"2018","unstructured":"Cerny M, Chernyak V, Olivi\u00e9 D, et al.. LI-RADS version 2018 ancillary features at MRI. Radiographics. 2018, 38:1973-2001. 10.1148\/rg.2018180052","journal-title":"Radiographics"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2025.08.006","article-title":"Diagnostic performance of diffusion weighted imaging for early response assessment after Y-90 transarterial radioembolization of hepatocellular carcinoma (HCC) - a systematic review and meta-analysis","volume":"55","author":"Loy LM","year":"2026","unstructured":"Loy LM, Acharyya S, Low HM, Pua U, Tan CH. Diagnostic performance of diffusion weighted imaging for early response assessment after Y-90 transarterial radioembolization of hepatocellular carcinoma (HCC) - a systematic review and meta-analysis. Curr Probl Diagn Radiol. 2026, 55:234-41. 10.1067\/j.cpradiol.2025.08.006","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112156","article-title":"DWI\/ADC in response assessment after local-regional treatment of HCC - pearls and pitfalls","volume":"188","author":"Loy LM","year":"2025","unstructured":"Loy LM, How GY, Low HM, Pua U, Hwee Quek LH, Tan CH. DWI\/ADC in response assessment after local-regional treatment of HCC - pearls and pitfalls. Eur J Radiol. 2025, 188:112156. 10.1016\/j.ejrad.2025.112156","journal-title":"Eur J Radiol"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.25.32745","article-title":"LI-RADS CT\/MRI radiation treatment response assessment version 2024: category redistribution and short-term outcomes in patients undergoing 90Y radioembolization for HCC","volume":"225","author":"Chiu SH","year":"2025","unstructured":"Chiu SH, Kesselman A, Yoon L, Kamaya A, Tse JR. LI-RADS CT\/MRI radiation treatment response assessment version 2024: category redistribution and short-term outcomes in patients undergoing 90Y radioembolization for HCC. AJR Am J Roentgenol. 2025, 225:e2532745. 10.2214\/AJR.25.32745","journal-title":"AJR Am J Roentgenol"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v14.i4.93461","article-title":"Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods","volume":"14","author":"Fathi M","year":"2024","unstructured":"Fathi M, Taher HJ, Al-Rubiae SJ, et al.. Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods. World J Methodol. 2024, 14:93461. 10.5662\/wjm.v14.i4.93461","journal-title":"World J Methodol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480067-liver-imaging-reporting-and-data-system-li-rads-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:40:02Z","timestamp":1785490802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480067-liver-imaging-reporting-and-data-system-li-rads-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":184,"URL":"https:\/\/doi.org\/10.7759\/cureus.113706","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}